ZEN Colombia Study: Zika in Pregnant Women and Children in Colombia
No material or nonsubstantive change to a currently approved collection
No
Regular
Approved without change
04/05/2018
03/27/2018
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
02/28/2021
02/28/2021
02/28/2021
73,250
0
71,450
14,736
0
14,211
0
0
0
Multiple projects have been jointly developed between INS and CDC, including enhanced surveillance of pregnant women with symptomatic Zika virus disease. CDC seeks to implement a prospective cohort study in which we will follow women enrolled in the first trimester of pregnancy, their male partners, and their children in several cities in Colombia in which ZIKV transmission is currently ongoing. This is a continuation study to collect data on the OMB-approved Emergency Clearance package 0920-1142, and the Standard ICR 0920-1190. This request for non-substantive change modifies some inclusion/exclusion criteria, a few questions, and permission for video recording.
Minor changes are requested for the inclusion/exclusion criteria and some of the forms to clarify responses. Minor changes in burden resulted from these edits.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.